We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Buckyballs to Fight Allergies

By Biotechdaily staff writers
Posted on 05 Jul 2007
Investigators identified a new biologic function for a molecule called a bucky ball--the ability to block the allergic response, setting the stage for the development of new therapies for allergy.

Allergic disease is the sixth leading cause of chronic disease in the United States, and while various treatments have been developed to control allergy, no cure has been found. More...
These findings advance the emerging field of medicine known as nanoimmunology. The researchers, from Virginia Commonwealth University (VCU; Richmond, VA, USA) and Luna Innovations, Inc. (Roanoke, VA, USA), a research company, are the first to demonstrate that buckyballs are able to block allergic response in human cell culture experiments.

Buckyballs, or fullerenes, are molecules composed entirely of carbon. Due to their unique structure, inertness and stability, researchers from a number of scientific fields have been investigating the tiny, hollow carbon cages to serve a variety of functions. In this study, scientists modified the buckyballs so that they were compatible with water.

"This discovery is exciting because it points to the possibility that these novel materials can one day lead to new therapies,” said Chris Kepley, Ph.D., M.B.A., assistant professor in the department of internal medicine, division of rheumatology, allergy, and immunology at the VCU School of Medicine. "Researchers in many fields are aware of the potential fullerenes have, however, we are the first to show they can turn off the allergic response and basic immune reactions.”

According to Dr. Kepley, who is the lead author of the study, the buckyballs are able to ‘interrupt' the allergy/immune response by suppressing a fundamental process in the cell that leads to the release of an allergic mediator. In essence, the buckyballs are able to prevent mast cells from releasing histamine.

Mast cells are responsible for causing allergic response and are stuffed with granules containing histamine. They are present in nearly all tissues except blood. When mast cells are triggered, inflammatory substances such as histamine, heparin, and a number of cytokines are quickly released into the tissues and blood, promoting an allergic response.
The researchers discovered that the unique structure of the buckyball enables it to bind to free radicals dramatically better than any anti-oxidant currently available, such as vitamin E. Free radicals are molecules that cause oxidative stress, which scientists believe may be the basis of aging.

The immune system both protects us and causes harm, so we are always interested in finding new pathways to help manage the harmful effects, said Dr. Kepley.

The new study findings were published online in the June 19, 2007, issue of the Journal of Immunology.


Related Links:
Luna Innovations Inc.
Virginia Commonwealth University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.